4ONCOMMUNITY is the virtual space where to examine and investigate information and knowledge about precision medicine for patients suffering from oncological pathologies.


The role of Predictive Molecular Pathology in clinical trials: the clinical value  I Dr. Paolo Nuciforo

The role of Predictive Molecular Pathology in clinical trials I Dr. Paolo Nuciforo

Biofluids in pathological anatomy I Dr. Matteo Fassan – Dr. Fabio Pagni – Dr. Nicola Fusco

Positive predictive markers of response in lung cancer I Dr. Umberto Malapelle

Welcome to Anne Schultheis

HER 2 evaluation in breast cancer: a focus on HER2 low expressed I Dr. Nicola Fusco

Colorectal MSI/MMR I
Dr. Matteo Fassan

Liquid Biopsy: new perspectives I Dr. Umberto Malapelle

Emerging markers in metastatic colorectal cancer: a focus on HER2 I Dr. Matteo Fassan

The new role of morphology in NSCLC I Dr.Fabio Pagni – Dr. Sara Pilotto

Predictive molecular pathology in NSCLC I Dr. Sara Pilotto – Dr. Umberto Malapelle

Networking and contamination: agnostic markers I 4ONCOMMUNITY BOARD

Lung cancer: state of the art | Dr. Umberto Malapelle – Dr.Fabio Pagni – Dr. Sara Pilotto

Liquid biopsy in breast cancer I Dr. Carmen Criscitiello – Dr. Umberto Malapelle

MSI/MMR as a transversal biomarkers I – Dr.Matteo Fassan – Dr. Umberto Malapelle – Dr. Nicola Fusco

Liquid Biopsy and Cancer Interception: perspectives from International Society of Liquid Biopsy I Professor Christian Rolfo

Latest updates from IASLC: Liquid Biopsy Hot Topic Meeting 2020 I Professor Umberto Malapelle

The role of the University in training professionals such as molecular pathologists |
Dr. Matteo Fassan

New challenges in breast pathology I Dr. Carmen Criscitiello

Latest updates from ESMO “Breast Cancer and Target Therapy” I Professor Nicola Fusco

Social Media in the Cancer Fight: the Oncoalert role I Doctor Gil Morgan

© 2020 4oncommunity – Powered & Design by Publics Icc with the contribution of Hu.Gen